| FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis (NCT00064441) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2003-05-01 |
| FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis (NCT00064454) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2003-05-01 |
| ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. (NCT00063830) | Ionis Pharmaceuticals, Inc. | 2003-04-03 |
| Cerebral Resonance Magnetic Imaging During Rectal Distention (NCT00213330) | University Hospital, Rouen | 2003-04-01 |
| Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis (NCT00259558) | Heidelberg University | 2003-04-01 |
| Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis (NCT00073047) | Facet Biotech | 2003-04-01 |
| Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis (NCT00259545) | Heidelberg University | 2003-02-01 |
| Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. (NCT00374725) | Odense University Hospital | 2003-02-01 |
| Quality of Life in Pediatric Inflammatory Bowel Disease (NCT00061737) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-01-01 |
| ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis (NCT00063414) | Ionis Pharmaceuticals, Inc. | 2002-11-20 |
| Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis (NCT00048347) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Clotrimazole Enemas for Pouchitis in Children and Adults (NCT00061282) | Web | 2002-09-30 |
| A Trial of Rosiglitazone for Ulcerative Colitis (NCT00065065) | James Lewis | 2002-09-01 |
| Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis (NCT00152841) | University Health Network, Toronto | 2002-06-01 |
| A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis (NCT00096655) | Centocor, Inc. | 2002-05-01 |
| Research Study in Patients With Severe Ulcerative Colitis (NCT00032305) | Facet Biotech | 2002-03-01 |
| Manitoba Inflammatory Bowel Disease Cohort Study (NCT03262649) | University of Manitoba | 2002-03-01 |
| A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis (NCT00036439) | Centocor, Inc. | 2002-02-01 |
| Probiotics in GastroIntestinal Disorders (NCT00510978) | University College Cork | 2002-01-01 |
| Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) (NCT00577473) | Warner Chilcott | 2001-02-01 |
| Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis (NCT00033943) | Incara Pharmaceuticals | 2001-01-01 |
| Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis (NCT00073021) | Warner Chilcott | 2000-09-01 |
| Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases (NCT00940576) | University of Jena | 2000-07-01 |
| Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis (NCT00463619) | Heidelberg University | 2000-04-01 |
| Immune Regulation in Ulcerative Colitis or Crohn s Disease (NCT00001184) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-08-07 |
| Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis (NCT00004810) | National Center for Research Resources (NCRR) | 1996-06-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| Monroe County Inflammatory Bowel Disease (IBD) Registry (NCT01032525) | University of Rochester | 1981-01-01 |
| Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch? (NCT01173250) | Mansoura University | |
| Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels (NCT01787786) | University of Western Ontario, Canada | |
| Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. (NCT00259571) | Heidelberg University | |
| Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA (NCT06856135) | Takeda | |
| Expanded Access to Upadacitinib (NCT04159597) | AbbVie | |